MELANIE STANISHIA: Open Payments
NPI 1235773953 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 122 payments from 14 companies in 2025. Trend: 2023 $2,043 · 2024 $1,506 · 2025 $2,137
Food & beverage: $2,028Education: $109
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 24 | $344 |
| Teva Pharmaceuticals USA, Inc. | 14 | $322 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $264 |
| Braeburn Inc. | 11 | $200 |
| Otsuka America Pharmaceutical, Inc. | 15 | $188 |
| Janssen Pharmaceuticals, Inc | 12 | $179 |
| Vanda Pharmaceuticals Inc. | 9 | $176 |
| Alkermes, Inc. | 10 | $172 |
| Axsome Therapeutics, Inc. | 7 | $129 |
| ABBVIE INC. | 4 | $70 |
Products named: COBENFY, CAPLYTA, BRIXADI, INVEGA SUSTENNA, ARISTADA, UZEDY, Auvelity, FANAPT.
Industry payments across KY — which companies pay providers there.
